Melhores Metástases hepáticas Metástases hepáticas em Israel - TOP-15 médicos

A Dra. Pelles Sharon chefia o Instituto de Tumores Gastrointestinais do Sourasky Medical Center – líder no tratamento de metástases hepáticas.

• Especializar-se no tratamento sistémico de cancros gastrointestinais
• Formar-se em oncologia no Royal Marsden Cancer Center, em Londres
• Desenvolver novos métodos para o tratamento do adenocarcinoma pancreático
• Realizar investigação molecular inovadora sobre tumores das vias biliares

O Prof. Merimsky lidera a Unidade de Oncologia de Partes Moles e Óssea no Sourasky Medical Center – um dos principais centros de oncologia de Israel.

• Mais de 20 anos de experiência especializada em oncologia ortopédica
• Especialização em tratamento de sarcoma no Institut Gustave Roussy, Paris
• Investigador principal no Instituto Weizmann e na Universidade de Tel Aviv
• Membro ativo do corpo docente de sarcoma da ESMO
• Publicação de inúmeros estudos sobre os resultados do tratamento do cancro

Prof. Ido Nachmany heads the Second Surgical Department at Sheba Medical Center. He specializes in HPB and robotic surgery for diseases of the liver, pancreas, and bile ducts, and for gastrointestinal neuroendocrine tumors. He also performs adrenal, spleen, and stomach surgery. Forbes listed him among Israel’s top physicians.

He advances minimally invasive robotic and laparoscopic techniques. The aim is better precision and faster recovery.

Credentials: Senior Lecturer at Tel Aviv University. Member of ASTS and IHPBA. Completed HPB and abdominal transplant fellowships at the Thomas E. Starzl Transplantation Institute. Board certified in General Surgery (Israel), Abdominal Organ Transplantation (ASTS), and HPB Surgery (University of Pittsburgh). He has published in Cancer Research, the Journal of the American College of Surgeons, and the European Journal of Surgical Oncology.

Dr. Einat Shacham‑Shmueli is a senior medical oncologist at the Gastrointestinal Clinic, Cancer Center, Sheba Medical Center. She treats cancers of the colon, stomach, and pancreas. She also manages metastatic disease. She uses precision diagnostics and biomarkers, systemic therapies, and radiotherapy. Care is provided within a multidisciplinary team.

She has authored more than 25 peer‑reviewed papers on GI oncology, tumor biology, and new treatments. Her work includes studies on stenting for malignant colonic obstruction. She serves as an investigator in international programs, including the NCI, the Radiation Therapy Oncology Group, and the Cancer Therapy Evaluation Program.

Education: MD, Tel Aviv University. Oncology residency, Tel Aviv Sourasky Medical Center. Advanced training in GI oncology, UCSF. Accreditations: Board certified in Oncology and Gastroenterology. Member, Israel Society of Oncology and Radiotherapy.

Dr. Yuri Goldes is a general surgeon with more than 20 years of clinical experience. He specializes in upper gastrointestinal and oncologic surgery. He is Deputy Director of the Department of General Surgery and Transplantation at Sheba Medical Center in Tel Aviv. He also leads the Upper GI Surgery Unit. He was named to Forbes Israel’s Best Doctors in 2025. He is ranked among Israel’s Best Gastrointestinal Surgeons by Forbes. In 2019, he received the Israeli Ministry of Health “Best Doctor of the Year” award.

He is an expert in advanced minimally invasive and robotic surgery. He treats diaphragmatic hernia, achalasia, GERD, and gallbladder disease. He also performs oncologic surgery for pancreatic, gastric, and esophageal cancers. He uses laparoscopic and robotic techniques.

He pioneered some of Israel’s first robotic oncologic resections of the stomach and pancreas. He is among a small group worldwide who perform minimally invasive Whipple procedures (pancreaticoduodenectomy) using advanced laparoscopy. He applies methods that improve outcomes and speed recovery. He provides personalized care.

O Dr. Ari Raphael lidera a Iniciativa Nacional de Medicina Genômica de Israel no Sourasky Medical Center, especializando-se em tratamentos oncológicos avançados.

• Professor sênior com extensa pesquisa em genômica e informática biomédica
• Investigador principal de múltiplos ensaios clínicos em câncer de pulmão e de mama
• Membro da Sociedade Europeia de Oncologia Médica (ESMO) e da Associação Internacional para o Estudo do Câncer de Pulmão (IASLC)
• Vencedor de múltiplas honras de ensino e pesquisa

Lidera a Divisão de Oncologia Médica do Sourasky Medical Center, um hospital de referência para cuidados oncológicos complexos.

• Oncologista sênior com vasta experiência clínica e de pesquisa
• Especialização no tratamento de metástases no fígado
• Formação em medicina interna para cuidados integrais do corpo
• Fluência em inglês para uma comunicação clara

Diretor de hospitalização oncológica no Centro Médico de Tel Aviv – O Dr. Stepfansky lidera uma equipa dedicada a casos de metástases hepáticas.

• Mais de 15 anos de experiência em oncologia
• Especializar-se em medicina interna e oncologia
• Ser um investigador ativo em ensaios clínicos para novos tratamentos de cancro
• Formar-se no Centro Médico de Tel Aviv, um dos melhores hospitais de Israel

O Dr. Ron Greenberg chefia o Departamento de Cirurgia Colorretal do Sourasky Medical Center. Ele traz mais de 20 anos de experiência como cirurgião abdominal.

• Realizar procedimentos abertos e minimamente invasivos
• Ser especialista em cirurgia pancreática complexa, como o procedimento de Whipple
• Liderar uma equipe cirúrgica dedicada em um grande hospital

Mais de 28 anos de experiência cirúrgica – O Dr. Ben-haim é especialista em cancros do fígado e do pâncreas no Sourasky Medical Center.

• Realizar procedimentos complexos de Whipple para cancros gastrointestinais
• Focar-se exclusivamente em cirurgias oncológicas
• Ser reconhecido entre os principais especialistas em cancro do fígado de Israel

Professor Raanan Berger, MD PhD, is a medical oncologist and radiotherapist. He is Director of the Cancer Center at Sheba Medical Center and heads its clinical research unit. He was listed in Forbes Israel’s “Best Doctors” (2025). He leads the genitourinary oncology program with a focus on prostate cancer. His care includes systemic therapy and radiotherapy in a multidisciplinary, patient-centered model.

He is board-certified in oncology. He earned his MD and PhD at Tel Aviv University and completed his clinical training at Sheba. He then completed a postdoctoral fellowship at Dana-Farber/Harvard, focusing on prostate cancer with Dr. Philip Kantoff and molecular oncology in Dr. William C. Hahn’s lab. He is a member of ESMO and ASCO. He has co-authored more than 20 peer-reviewed papers, including studies on outcomes in high- versus very high-risk prostate cancer and on BRCA1/2 in large cohorts.

Prof. Ben Boursi is a physician in the Gastrointestinal Cancer Department at Sheba Medical Center. He specializes in internal medicine, medical oncology, and cancer epidemiology. He is board certified in internal medicine and medical oncology. He earned a B.Med.Sc (summa cum laude) and an MD (magna cum laude) from Tel Aviv University.

He completed clinical and research fellowships in GI oncology and cancer epidemiology at the University of Pennsylvania. He also completed electives at MD Anderson and Mayo Clinic. He founded the ECOG-ACRIN Microbiome Working Group. His microbiome-oncology research has been published in leading journals, including Science, and highlighted by ASCO.

He developed predictive models for early diagnosis of colorectal and pancreatic cancers. These models are now in clinical evaluation. He holds an academic appointment at Tel Aviv University. He is also an Associate Scholar at the University of Pennsylvania.

Dr. Yaacov Lawrence, MA, MBBS, MRCP, is Chair of Radiation Oncology at Sheba Medical Center. He has nearly 30 years of experience in precision radiation oncology and neuro-oncology.

He is an expert in advanced radiation therapy and radiosurgery. He performs stereotactic radiosurgery for brain tumors. He leads Sheba’s GI Cancer Program in gastrointestinal oncology. He also provides precision care for lung and prostate cancers. He pioneered celiac plexus radiosurgery for severe pain from pancreatic cancer.

Training and credentials: MA and MBBS (Cambridge and UCLH); MRCP (RCP); Radiation Oncology fellowship (Thomas Jefferson University). Honors include the ASCO Young Investigator Award and Fellow of ASTRO (FASTRO). He has authored over 280 publications. He is Director of the Center for Translational Radiation Oncology and an Associate Professor at Tel Aviv University.

O Professor Rifaat Safadi chefia a unidade de doenças hepáticas do Centro Médico Hadassah, especializando-se em tratamentos hepáticos avançados com reconhecimento internacional.

• Formado sob a orientação do Professor Scott Friedman na Sinai School of Medicine em Nova York
• Membro de associações internacionais para o estudo do fígado
• Premiado por pesquisas sobre modulação imunológica da fibrose hepática
• Autor de inúmeros artigos em hepatologia
• Chefe da unidade de doenças hepáticas no Centro Médico Hadassah